Sumitomo Dainippon Pharma Advertiser Profile
Oncology Pharmaceutical Company
13-1 Kyobashi , Chuo Kiu, Tokyo, JP 104-8356
81351592500
Sumitomo Dainippon Pharma is part of Sumitovant Biopharma Ltd.. They spent under $100 million on advertising in digital, print, and national TV in the last year. They invest in premium ad units and advertised on over 100 different Media Properties in the last year across multiple Media formats. Sumitomo Dainippon Pharma launched and advertised 1 new product in the past twelve months.
We have key contact information for decision makers at Sumitomo Dainippon Pharma.
We have key contact information for decision makers at Sumitomo Dainippon Pharma.
Summary
Sumitomo Dainippon Pharma is part of Sumitovant Biopharma Ltd.. They spent under $100 million on advertising in digital, print, and national TV in the last year. They invest in premium ad units and advertised on over 100 different Media Properties in the last year across multiple Media formats. Sumitomo Dainippon Pharma launched and advertised 1 new product in the past twelve months.
We have key contact information for decision makers at Sumitomo Dainippon Pharma.
We have key contact information for decision makers at Sumitomo Dainippon Pharma.
MediaRadar helps advertising sales teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.
We have contact information for decision makers at Sumitomo Dainippon Pharma, including Executives, Strategists, Media Buyers and Agency contacts.
Danielle C.
Supervisor, Digital Investment
Daniel B.
Director, Market Access Marketing
Amy M.
Director of Customer Marketing, HCP Omnichannel Engagement
Key Contacts
MediaRadar helps advertising sales teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.
We have contact information for decision makers at Sumitomo Dainippon Pharma, including Executives, Strategists, Media Buyers and Agency contacts.
Danielle C.
Supervisor, Digital Investment
Daniel B.
Director, Market Access Marketing
Amy M.
Director of Customer Marketing, HCP Omnichannel Engagement
MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Sumitomo Dainippon Pharma and its subsidiaries.
Snapchat
Last ran on Snapchat on 8/1/2022.
Display
Last ran on One37PM on 5/1/2023.
TV
Last ran on Science on 10/31/2022.
Snapchat
Last ran on Snapchat on 8/1/2022.
Display
Last ran on One37PM on 5/1/2023.
TV
Last ran on Science on 10/31/2022.
Recent Ad Creative
MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Sumitomo Dainippon Pharma and its subsidiaries.
Snapchat
Last ran on Snapchat on 8/1/2022.
Display
Last ran on One37PM on 5/1/2023.
TV
Last ran on Science on 10/31/2022.
Snapchat
Last ran on Snapchat on 8/1/2022.
Display
Last ran on One37PM on 5/1/2023.
TV
Last ran on Science on 10/31/2022.
MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Sumitomo Dainippon Pharma Advertising Spend:
UNDER $100 Million
Decreased Spending YoY
- Sumitomo Dainippon Pharma recently bought a Page Takeover digital ad. See which other premium units they bought.
- Sumitomo Dainippon Pharma recently placed a direct ad on www.webmd.com/bipolar-disorder/default.htm. See where else they recently placed direct ads.
- Sumitomo Dainippon Pharma recently placed a programmatic ad on www.one37pm.com/. In the last 12 months, they have partnered with DoubleClick and 6 other providers. Which providers do they use most?
Media Spend
MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Sumitomo Dainippon Pharma Advertising Spend:
UNDER $100 Million
Decreased Spending YoY
- Sumitomo Dainippon Pharma recently bought a Page Takeover digital ad. See which other premium units they bought.
- Sumitomo Dainippon Pharma recently placed a direct ad on www.webmd.com/bipolar-disorder/default.htm. See where else they recently placed direct ads.
- Sumitomo Dainippon Pharma recently placed a programmatic ad on www.one37pm.com/. In the last 12 months, they have partnered with DoubleClick and 6 other providers. Which providers do they use most?
MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 27,712 new product launches overall.
Sumitomo Dainippon Pharma launched a campaign supporting 1 new product line in the last twelve months, Stedesa.
New Product Launches
MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 27,712 new product launches overall.
Sumitomo Dainippon Pharma launched a campaign supporting 1 new product line in the last twelve months, Stedesa.